On sale!

Semaglutide 2mg – Ozempic – Fat-Burning Peptide

The original price was: €44.The current price is: 42 €.

Semaglutide 2mg – Ozempic

Composition: Semaglutide 2 mg
Category: Peptide
Indication: Weight management and appetite modulation
Pharmaceutical form: Vial containing 2 mg of lyophilized powder with separate 1 ml ampoule of water for injections, intended for reconstitution
Route of administration: Subcutaneous injection

  • Check Mark Shipping (if the product is in stock): 3 business days for processing and 5 to 20 business days for shipping
  • Check Mark Processing and shipping costs: €27 throughout Italy
  • Stripe
  • Visa Card
  • MasterCard
  • American Express
  • Discover Card
  • PayPal
  • Apple Pay
Available payment methods: Bitcoin - Bank transfer - Credit card - Neteller

What is Ozempic (Semaglutide)?

Ozempic is a drug based on Semaglutide, a peptide GLP-1 receptor agonist developed for the treatment of type 2 diabetes and now widely used for weight management and metabolic health.

Semaglutide works by mimicking the intestinal hormone GLP-1, which is responsible for regulating satiety, appetite, and blood sugar control. Thanks to this mechanism, Ozempic effectively reduces hunger and promotes gradual, sustainable weight loss.


Main effects of Ozempic (Semaglutide)

🍽 Appetite control
Semaglutide reduces hunger signals in the brain and slows gastric emptying, prolonging the feeling of fullness after meals.

🩸 Blood sugar control
Ozempic stimulates insulin secretion in response to meals and reduces glucagon release, helping to stabilize blood sugar levels, especially in the presence of insulin resistance.

⚖️ Weight loss
Thanks to reduced calorie intake and better appetite control, Semaglutide promotes fat loss without resorting to extreme diets.

🫀 Metabolic and cardiovascular support
The use of Ozempic is often associated with improvements in blood pressure, lipid profile, and inflammatory markers, reducing overall metabolic risk.


How to take Ozempic (Semaglutide)

Semaglutide is supplied in a vial containing 2 mg of lyophilized powder and must be reconstituted with water for injections before use.
It is administered by weekly subcutaneous injection, always on the same day.

Indicative dosage schedule

  • Weeks 1–4: 0.25 mg

  • Weeks 5–8: 0.5 mg

  • Weeks 9–12: 1.0 mg

  • Week 13+: up to 2.0 mg (only if necessary and well tolerated)

It is not necessary to increase the dose if the current dose is already effective and well tolerated.


Precautions and side effects

Possible side effects:

  • Nausea (more common in the first few weeks)

  • Reduced appetite

  • Bloating or mild digestive problems

  • Headache or fatigue

Main contraindications:

  • Personal or family history of medullary thyroid carcinoma or MEN2 syndrome

  • Pregnancy and breastfeeding

  • Concomitant use with other GLP-1 agonists (e.g., tirzepatide, retatrutide)


Storage

  • Store in the refrigerator at 2–8 °C.

  • Do not freeze

  • Protect from light

  • After reconstitution, use within approximately 30 days.